Business News: Organon to Buy Dermavant including Tapinarof Cream, 1%(Vtama)
Organon is acquiring Dermavant Sciences Ltd. Dermavant’s novel product, tapinarof cream, 1% (Vtama) for the topical treatment of mild, moderate, and severe plaque psoriasis in adults, was approved by the U.S. Food and Drug Administration (FDA) in May 2022. The FDA is reviewing a Supplemental New Drug Application (sNDA) for tapinarof cream, 1% as a […]